Scarica l'app Stockscreener
1.32
0.75%
-0.01
Inmed Pharmaceuticals Inc Borsa (INM) Ultime notizie
At $1.32–$1.33 a share, ADAR1 funds buy 9,569 shares of InMed Pharmaceuticals (INM). - Stock Titan
Form 4 InMed Pharmaceuticals Inc. For: 12 October By Investing.com - Investing.com South Africa
Form 4 InMed Pharmaceuticals Inc. For: 8 October By Investing.com - Investing.com South Africa
Form 4 InMed Pharmaceuticals Inc. For: 8 October By Investing.com - Investing.com UK
Across October 6–8, ADAR1 funds buy 10,903 shares of InMed Pharmaceuticals (INM). - Stock Titan
Funds hold 943,668 InMed Pharmaceuticals (INM) shares, with voting power shared by two reporting persons. - Stock Titan
Across three transactions, ADAR1 funds buy 42,920 InMed Pharmaceuticals (INM) shares. - Stock Titan
Form 8K INMED PHARMACEUTICALS INC. For: 18 September By Investing.com - Investing.com Nigeria
Nasdaq gives InMed 45 days to submit a compliance plan - Stock Titan
10% owner adds to InMed Pharmaceuticals (INM) stake with open-market buys - Stock Titan
InMed Reports FY2026 Net Loss Of $12.9 Million As Mentari Merger Advances With $490 Million Financing - Pulse 2.0
InMed winds down only revenue-generating business BayMedica - Minichart
[S-4/A] InMed Pharmaceuticals Inc. Amended Business Combination Registration | INM SEC FilingForm S-4/A - Stock Titan
$490M backs proposed migraine merger at InMed Pharmaceuticals (INM)—what legacy holders keep - Stock Titan
InMed Pharmaceuticals Inc. FY 2026: Revenue $3.18M, EPS ($3.12) — 10-K Summary - TradingView
About $490 million in financing is expected before a proposed merger. InMed still needs shareholder approval. - Stock Titan
InMed Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
GOOG: Alphabet IncOrdinary SharesClass C Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
InMed (INM) Earnings Update: The Company Publishes Its Latest Results in the Latest Session; Price Reaction: Shares Close 7.59% Lower for the Current SessionSegment Revenue Breakdown - vinanet.vn
InMed (INM) Price: Finishes 7.59% Down at $1.46 in the Latest Session; Technical Setup: Price Remains Between $1.39 Support and $1.53 Resistance under the Current SnapshotIntraday Profile - vinanet.vn
InMed (INM) Price: Finishes 7.59% Down at $1.46 in the Latest Session; Technical Setup: Price Remains Between $1.39 Support and $1.53 Resistance under the Current SnapshotShort Setup Alerts - siam.in
InMed (INM) Price: Finishes 7.59% Down at $1.46 in the Latest Session; Technical Setup: Price Remains Between $1.39 Support and $1.53 Resistance under the Current SnapshotVol Target Rebalance - dars.gov.et
InMed (INM) Q3 2025 Results: The Latest Report Adds New Financial Reference Points at the Close; Session Move: Shares Move 0.63% Lower in the Current UpdateEarnings Growth Forecast - vinanet.vn
InMed (INM) Session: Adds 0.63% to Close at $1.60 in Latest Trading; Current Setup: Traders Can Monitor the $1.52-$1.68 RangeVolatility Skew - vinanet.vn
InMed (INM) Q3 2025 Results: The Latest Report Adds New Financial Reference Points at the Close; Session Move: Shares Move 0.63% Lower in the Current UpdateAnalyst Earnings Estimate - careplusvn.com
InMed (INM) Session: Adds 0.63% to Close at $1.60 in Latest Trading; Current Setup: Traders Can Monitor the $1.52-$1.68 RangeBollinger Walk - dars.gov.et
InMed (INM) Q3 2025 Results: The Latest Report Adds New Financial Reference Points at the Close; Session Move: Shares Move 0.63% Lower in the Current UpdateNegative Surprise Momentum - dars.gov.et
InMed (INM) Q3 2025 Results: The Latest Report Adds New Financial Reference Points at the Close; Session Move: Shares Move 0.63% Lower in the Current UpdateAnalyst Consensus Shift - dars.gov.et
InMed (INM) Q3 2025 Results: The Latest Report Adds New Financial Reference Points at the Close; Session Move: Shares Move 0.63% Lower in the Current UpdateRevenue Per Share - dars.gov.et
InMed (INM) Q3 2025 Results: The Latest Report Adds New Financial Reference Points at the Close; Session Move: Shares Move 0.63% Lower in the Current UpdateEarnings Surprise Stocks - dars.gov.et
InMed (INM) Q3 2025 Results: The Latest Report Adds New Financial Reference Points at the Close; Session Move: Shares Move 0.63% Lower in the Current UpdateUpward Estimate Revision - dars.gov.et
InMed Pharmaceuticals (INM) Holds Above Support After 2.8% GainCash Secured Put - vinanet.vn
InMed Pharmaceuticals (INM) Holds Above Support After 2.8% GainKey Reversal Day - dars.gov.et
INM Q3 2025 Earnings: Net Loss of $1.94 Per Share; Stock Rises 2.8%One-Time Gain Impact - vinanet.vn
InMed Pharmaceuticals (INM) investor reports 4.2% beneficial stake in 137,634 shares - Stock Titan
Inmed Pharmaceuticals Stock Price Forecast. Should You Buy INM? - StockInvest.us
INM Q3 2025 Earnings: Net Loss of $1.94 Per Share Reflects Ongoing Biopharmaceutical InvestmentRevenue Breakdown Analysis - vinanet.vn
INM Q3 2025 Earnings: Net Loss of $1.94 Per Share ReportedFinancial Data - Vinanet
InMed Pharmaceuticals (INM) Rises 3.55% to $1.46 as Buyers Defend Key SupportMA Crossover - dars.gov.et
InMed Pharmaceuticals (INM) Rises 3.55% to $1.46 as Buyers Defend Key SupportBlue Chip Entry Points - vinanet.vn
InMed Pharmaceuticals Inc (INM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
InMed Pharmaceuticals (INM) Slips 6% to $1.40 as Support Level Comes into FocusDefined Outcome ETF - vinanet.vn
InMed Pharmaceuticals (INM) Rises 2.40% as Shares Approach Key $1.58 ResistanceSector Leader Stocks - vinanet.vn
INM Q3 2025 Earnings: Net Loss of $1.94 Per Share Reflects Ongoing Clinical InvestmentNet Profit Margin - vinanet.vn
INM Q3 2025 Earnings: Narrowing Losses and Cautious Pipeline ProgressRevenue Growth Report - vinanet.vn
InMed Pharmaceuticals Inc (INM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
InMed Pharmaceuticals Inc (INM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
InMed Pharmaceuticals Inc (INM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
InMed Pharmaceuticals Inc (INM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
InMed Pharmaceuticals Inc (INM) Institutional Confidence - TradingKey
7.97%
3.58%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):